Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Shoulder Joint | 182 | 2023 | 572 | 30.890 |
Why?
|
Arthroplasty, Replacement, Shoulder | 59 | 2023 | 164 | 16.620 |
Why?
|
Baseball | 37 | 2022 | 105 | 14.670 |
Why?
|
Arthroscopy | 125 | 2023 | 811 | 13.260 |
Why?
|
Rotator Cuff Injuries | 73 | 2023 | 280 | 12.290 |
Why?
|
Tenodesis | 40 | 2023 | 152 | 12.110 |
Why?
|
Joint Instability | 61 | 2021 | 387 | 10.380 |
Why?
|
Rotator Cuff | 65 | 2023 | 265 | 9.960 |
Why?
|
Shoulder Injuries | 42 | 2023 | 139 | 9.300 |
Why?
|
Tendon Injuries | 36 | 2023 | 196 | 8.030 |
Why?
|
Elbow Joint | 30 | 2022 | 131 | 7.620 |
Why?
|
Range of Motion, Articular | 97 | 2021 | 699 | 6.840 |
Why?
|
Return to Sport | 24 | 2021 | 120 | 6.770 |
Why?
|
Tendons | 34 | 2023 | 218 | 6.590 |
Why?
|
Collateral Ligament, Ulnar | 12 | 2022 | 28 | 6.400 |
Why?
|
Shoulder Dislocation | 24 | 2021 | 94 | 6.330 |
Why?
|
Humans | 380 | 2023 | 29351 | 6.260 |
Why?
|
Athletic Injuries | 30 | 2020 | 178 | 6.250 |
Why?
|
Shoulder | 34 | 2021 | 154 | 5.960 |
Why?
|
Osteoarthritis | 24 | 2023 | 363 | 5.310 |
Why?
|
Ulnar Collateral Ligament Reconstruction | 9 | 2022 | 18 | 5.210 |
Why?
|
Orthopedic Procedures | 28 | 2020 | 317 | 5.180 |
Why?
|
Muscle, Skeletal | 30 | 2023 | 349 | 5.060 |
Why?
|
Scapula | 28 | 2022 | 79 | 5.060 |
Why?
|
Postoperative Complications | 41 | 2023 | 957 | 4.950 |
Why?
|
Humerus | 30 | 2022 | 98 | 4.600 |
Why?
|
Arthroplasty, Replacement | 23 | 2020 | 147 | 4.480 |
Why?
|
Treatment Outcome | 114 | 2023 | 3475 | 4.470 |
Why?
|
Male | 193 | 2022 | 15633 | 4.430 |
Why?
|
Glenoid Cavity | 12 | 2022 | 34 | 4.350 |
Why?
|
Adult | 142 | 2022 | 8594 | 4.260 |
Why?
|
Hemiarthroplasty | 10 | 2019 | 31 | 4.090 |
Why?
|
Middle Aged | 149 | 2022 | 9818 | 4.020 |
Why?
|
Reoperation | 43 | 2020 | 932 | 3.960 |
Why?
|
Collateral Ligaments | 7 | 2022 | 25 | 3.940 |
Why?
|
Retrospective Studies | 90 | 2023 | 3273 | 3.850 |
Why?
|
Biomechanical Phenomena | 53 | 2022 | 668 | 3.740 |
Why?
|
Shoulder Pain | 19 | 2020 | 55 | 3.620 |
Why?
|
Female | 171 | 2022 | 16205 | 3.520 |
Why?
|
Young Adult | 60 | 2022 | 1933 | 3.410 |
Why?
|
Arthroplasty | 18 | 2022 | 136 | 3.400 |
Why?
|
Shoulder Prosthesis | 13 | 2022 | 19 | 3.220 |
Why?
|
Tendinopathy | 11 | 2020 | 60 | 3.030 |
Why?
|
Aged | 104 | 2022 | 9441 | 2.600 |
Why?
|
Ligaments, Articular | 9 | 2019 | 104 | 2.590 |
Why?
|
Adolescent | 52 | 2021 | 2275 | 2.580 |
Why?
|
Follow-Up Studies | 42 | 2021 | 1829 | 2.520 |
Why?
|
Suture Techniques | 31 | 2020 | 141 | 2.490 |
Why?
|
Tenotomy | 6 | 2021 | 16 | 2.490 |
Why?
|
Bone Screws | 17 | 2020 | 181 | 2.470 |
Why?
|
Pectoralis Muscles | 7 | 2016 | 18 | 2.430 |
Why?
|
Shoulder Fractures | 6 | 2020 | 26 | 2.320 |
Why?
|
Athletic Performance | 5 | 2020 | 18 | 2.230 |
Why?
|
Osteotomy | 10 | 2022 | 163 | 2.170 |
Why?
|
Tibia | 8 | 2018 | 259 | 2.080 |
Why?
|
Recovery of Function | 24 | 2019 | 290 | 2.020 |
Why?
|
Hamstring Muscles | 3 | 2019 | 14 | 2.000 |
Why?
|
Patient Readmission | 5 | 2019 | 123 | 1.960 |
Why?
|
Suture Anchors | 14 | 2020 | 71 | 1.920 |
Why?
|
Postoperative Period | 19 | 2021 | 288 | 1.870 |
Why?
|
Patient Satisfaction | 12 | 2021 | 294 | 1.830 |
Why?
|
Fracture Fixation, Internal | 3 | 2019 | 71 | 1.790 |
Why?
|
Cadaver | 36 | 2020 | 359 | 1.790 |
Why?
|
Tomography, X-Ray Computed | 18 | 2020 | 770 | 1.770 |
Why?
|
Acromioclavicular Joint | 8 | 2019 | 18 | 1.710 |
Why?
|
Joint Prosthesis | 6 | 2015 | 83 | 1.670 |
Why?
|
Acromion | 7 | 2021 | 26 | 1.610 |
Why?
|
Bone Transplantation | 11 | 2019 | 224 | 1.560 |
Why?
|
Upper Extremity | 7 | 2019 | 49 | 1.540 |
Why?
|
Superficial Back Muscles | 3 | 2021 | 3 | 1.530 |
Why?
|
Orthopedics | 5 | 2020 | 127 | 1.520 |
Why?
|
Databases, Factual | 14 | 2020 | 330 | 1.510 |
Why?
|
Rotator Cuff Tear Arthropathy | 5 | 2021 | 12 | 1.500 |
Why?
|
Radiography | 24 | 2020 | 678 | 1.500 |
Why?
|
Rotation | 19 | 2021 | 142 | 1.470 |
Why?
|
Aged, 80 and over | 43 | 2021 | 4844 | 1.460 |
Why?
|
Decompression, Surgical | 7 | 2019 | 141 | 1.440 |
Why?
|
Athletes | 8 | 2022 | 76 | 1.420 |
Why?
|
Bankart Lesions | 2 | 2020 | 8 | 1.390 |
Why?
|
Pain Measurement | 20 | 2020 | 462 | 1.380 |
Why?
|
Debridement | 12 | 2019 | 100 | 1.340 |
Why?
|
United States | 23 | 2023 | 2331 | 1.330 |
Why?
|
Time Factors | 22 | 2020 | 1615 | 1.320 |
Why?
|
Bone Resorption | 7 | 2019 | 104 | 1.310 |
Why?
|
Ambulatory Surgical Procedures | 5 | 2020 | 74 | 1.290 |
Why?
|
Age Factors | 12 | 2020 | 839 | 1.240 |
Why?
|
Imaging, Three-Dimensional | 13 | 2021 | 222 | 1.230 |
Why?
|
Risk Factors | 20 | 2021 | 2436 | 1.210 |
Why?
|
Treatment Failure | 9 | 2020 | 159 | 1.200 |
Why?
|
Humeral Fractures | 3 | 2017 | 22 | 1.200 |
Why?
|
Evidence-Based Medicine | 8 | 2020 | 208 | 1.170 |
Why?
|
Cumulative Trauma Disorders | 4 | 2016 | 16 | 1.150 |
Why?
|
Cohort Studies | 19 | 2020 | 1937 | 1.120 |
Why?
|
Surveys and Questionnaires | 18 | 2019 | 1181 | 1.120 |
Why?
|
Return to Work | 5 | 2021 | 52 | 1.110 |
Why?
|
Patient Reported Outcome Measures | 14 | 2021 | 379 | 1.110 |
Why?
|
Recurrence | 20 | 2021 | 348 | 1.100 |
Why?
|
Lacerations | 3 | 2015 | 16 | 1.080 |
Why?
|
Rupture | 14 | 2019 | 115 | 1.070 |
Why?
|
Exercise Therapy | 4 | 2017 | 112 | 1.040 |
Why?
|
Internship and Residency | 4 | 2019 | 211 | 1.020 |
Why?
|
Surgeons | 3 | 2020 | 76 | 1.020 |
Why?
|
Cartilage, Articular | 11 | 2018 | 524 | 1.010 |
Why?
|
Platelet-Rich Plasma | 7 | 2017 | 75 | 0.990 |
Why?
|
Joint Diseases | 11 | 2019 | 110 | 0.980 |
Why?
|
Arthritis | 5 | 2020 | 107 | 0.960 |
Why?
|
Wound Healing | 12 | 2021 | 168 | 0.950 |
Why?
|
Surgical Wound Infection | 4 | 2020 | 97 | 0.950 |
Why?
|
Magnetic Resonance Imaging | 16 | 2023 | 1222 | 0.940 |
Why?
|
Iatrogenic Disease | 2 | 2020 | 26 | 0.910 |
Why?
|
Length of Stay | 6 | 2021 | 317 | 0.900 |
Why?
|
Prosthesis Design | 12 | 2020 | 502 | 0.870 |
Why?
|
Weight-Bearing | 6 | 2020 | 164 | 0.860 |
Why?
|
Peripheral Nerve Injuries | 3 | 2020 | 16 | 0.860 |
Why?
|
Propionibacterium acnes | 2 | 2020 | 8 | 0.850 |
Why?
|
Occupational Injuries | 2 | 2019 | 8 | 0.840 |
Why?
|
Postoperative Care | 12 | 2020 | 127 | 0.840 |
Why?
|
Fractures, Stress | 2 | 2019 | 22 | 0.830 |
Why?
|
Nanofibers | 1 | 2021 | 2 | 0.830 |
Why?
|
Humeral Head | 7 | 2021 | 26 | 0.830 |
Why?
|
Child | 16 | 2021 | 1345 | 0.820 |
Why?
|
Muscular Dystrophy, Facioscapulohumeral | 2 | 2012 | 2 | 0.810 |
Why?
|
Nerve Compression Syndromes | 3 | 2010 | 26 | 0.810 |
Why?
|
Incidence | 10 | 2019 | 752 | 0.810 |
Why?
|
Ribs | 2 | 2012 | 15 | 0.800 |
Why?
|
Physical Examination | 9 | 2018 | 117 | 0.780 |
Why?
|
Absorbable Implants | 6 | 2021 | 24 | 0.770 |
Why?
|
Venous Thromboembolism | 1 | 2021 | 37 | 0.760 |
Why?
|
Education, Medical, Graduate | 3 | 2019 | 79 | 0.750 |
Why?
|
Elbow | 4 | 2021 | 42 | 0.740 |
Why?
|
Physical Therapy Modalities | 4 | 2018 | 80 | 0.740 |
Why?
|
Opioid-Related Disorders | 2 | 2019 | 49 | 0.720 |
Why?
|
Patient Outcome Assessment | 2 | 2017 | 43 | 0.720 |
Why?
|
Olecranon Process | 1 | 2019 | 2 | 0.710 |
Why?
|
Sternoclavicular Joint | 1 | 2019 | 6 | 0.710 |
Why?
|
Electromyography | 4 | 2017 | 78 | 0.700 |
Why?
|
Ulnar Nerve | 1 | 2019 | 2 | 0.700 |
Why?
|
Ulnar Nerve Compression Syndromes | 1 | 2019 | 2 | 0.700 |
Why?
|
Elective Surgical Procedures | 1 | 2019 | 43 | 0.680 |
Why?
|
Arm Injuries | 2 | 2016 | 11 | 0.670 |
Why?
|
Arm | 8 | 2022 | 78 | 0.660 |
Why?
|
Patient Selection | 5 | 2013 | 232 | 0.660 |
Why?
|
Doxycycline | 1 | 2018 | 22 | 0.660 |
Why?
|
Health Care Surveys | 2 | 2017 | 67 | 0.660 |
Why?
|
Clavicle | 3 | 2016 | 15 | 0.660 |
Why?
|
Coronavirus Infections | 1 | 2020 | 86 | 0.650 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 89 | 0.650 |
Why?
|
Sex Factors | 4 | 2017 | 495 | 0.650 |
Why?
|
Joint Capsule Release | 1 | 2018 | 6 | 0.650 |
Why?
|
Pandemics | 1 | 2020 | 236 | 0.640 |
Why?
|
Bursitis | 1 | 2018 | 10 | 0.640 |
Why?
|
Coracoid Process | 2 | 2017 | 6 | 0.640 |
Why?
|
Pelvic Exenteration | 1 | 2017 | 1 | 0.630 |
Why?
|
Genital Neoplasms, Female | 1 | 2017 | 10 | 0.620 |
Why?
|
Pneumonia | 1 | 2018 | 67 | 0.620 |
Why?
|
Pulmonary Embolism | 1 | 2018 | 59 | 0.620 |
Why?
|
Hospital Charges | 1 | 2017 | 17 | 0.620 |
Why?
|
Body Mass Index | 3 | 2020 | 426 | 0.620 |
Why?
|
Fever | 1 | 2017 | 40 | 0.620 |
Why?
|
Disease Management | 1 | 2018 | 114 | 0.620 |
Why?
|
Analgesics, Opioid | 2 | 2020 | 215 | 0.610 |
Why?
|
Pain, Postoperative | 3 | 2019 | 314 | 0.610 |
Why?
|
Prospective Studies | 13 | 2023 | 1808 | 0.610 |
Why?
|
Muscle Fatigue | 2 | 2017 | 10 | 0.610 |
Why?
|
Patient Positioning | 5 | 2020 | 38 | 0.600 |
Why?
|
Ilium | 2 | 2014 | 31 | 0.590 |
Why?
|
Acellular Dermis | 2 | 2013 | 6 | 0.590 |
Why?
|
Allografts | 7 | 2021 | 180 | 0.580 |
Why?
|
Osteochondritis Dissecans | 3 | 2015 | 27 | 0.580 |
Why?
|
Transplantation, Homologous | 10 | 2018 | 277 | 0.580 |
Why?
|
Dyskinesias | 1 | 2016 | 35 | 0.580 |
Why?
|
Finite Element Analysis | 1 | 2016 | 44 | 0.580 |
Why?
|
Prosthesis-Related Infections | 2 | 2019 | 214 | 0.570 |
Why?
|
Case-Control Studies | 8 | 2017 | 636 | 0.570 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2017 | 184 | 0.560 |
Why?
|
Minimal Clinically Important Difference | 4 | 2021 | 106 | 0.560 |
Why?
|
Menisci, Tibial | 3 | 2013 | 172 | 0.540 |
Why?
|
Tennis Elbow | 3 | 2010 | 13 | 0.530 |
Why?
|
Workers' Compensation | 6 | 2021 | 59 | 0.520 |
Why?
|
Quality Improvement | 1 | 2016 | 158 | 0.520 |
Why?
|
Anti-Bacterial Agents | 1 | 2018 | 402 | 0.520 |
Why?
|
Shoulder Impingement Syndrome | 2 | 2014 | 11 | 0.510 |
Why?
|
Wounds and Injuries | 3 | 2011 | 44 | 0.490 |
Why?
|
Transplantation, Autologous | 7 | 2019 | 195 | 0.490 |
Why?
|
Computer Simulation | 5 | 2019 | 218 | 0.490 |
Why?
|
Radius | 3 | 2018 | 32 | 0.470 |
Why?
|
Musculoskeletal Manipulations | 1 | 2013 | 5 | 0.470 |
Why?
|
Skin Transplantation | 1 | 2013 | 16 | 0.470 |
Why?
|
Joint Capsule | 4 | 2008 | 43 | 0.460 |
Why?
|
Salvage Therapy | 3 | 2020 | 36 | 0.460 |
Why?
|
Foreign-Body Reaction | 1 | 2013 | 32 | 0.450 |
Why?
|
Risk Assessment | 9 | 2021 | 679 | 0.450 |
Why?
|
Preoperative Period | 4 | 2020 | 65 | 0.450 |
Why?
|
Reproducibility of Results | 7 | 2020 | 788 | 0.440 |
Why?
|
Pain | 6 | 2022 | 391 | 0.440 |
Why?
|
Cartilage | 1 | 2013 | 148 | 0.440 |
Why?
|
Brachial Plexus Neuropathies | 1 | 2012 | 3 | 0.430 |
Why?
|
Osteoarthritis, Hip | 1 | 2013 | 94 | 0.430 |
Why?
|
Movement | 4 | 2016 | 143 | 0.430 |
Why?
|
Hand Injuries | 2 | 2009 | 13 | 0.430 |
Why?
|
Monitoring, Intraoperative | 1 | 2012 | 37 | 0.420 |
Why?
|
Arthrodesis | 1 | 2012 | 40 | 0.420 |
Why?
|
Preoperative Care | 7 | 2020 | 135 | 0.410 |
Why?
|
Arthroplasty, Subchondral | 3 | 2019 | 27 | 0.390 |
Why?
|
Arthralgia | 4 | 2016 | 121 | 0.380 |
Why?
|
Diagnosis, Differential | 5 | 2013 | 389 | 0.370 |
Why?
|
Comorbidity | 5 | 2020 | 498 | 0.360 |
Why?
|
Visual Analog Scale | 3 | 2019 | 49 | 0.350 |
Why?
|
Surgery, Computer-Assisted | 2 | 2020 | 60 | 0.350 |
Why?
|
Competitive Behavior | 2 | 2019 | 7 | 0.350 |
Why?
|
Algorithms | 4 | 2019 | 400 | 0.350 |
Why?
|
Simulation Training | 2 | 2019 | 34 | 0.320 |
Why?
|
Inpatients | 2 | 2021 | 141 | 0.320 |
Why?
|
Cross-Sectional Studies | 3 | 2016 | 958 | 0.320 |
Why?
|
Sheep | 3 | 2023 | 39 | 0.310 |
Why?
|
Clinical Competence | 3 | 2019 | 230 | 0.310 |
Why?
|
Minimally Invasive Surgical Procedures | 2 | 2010 | 300 | 0.310 |
Why?
|
Sutures | 5 | 2019 | 41 | 0.300 |
Why?
|
Deltoid Muscle | 2 | 2018 | 6 | 0.300 |
Why?
|
Neurosurgical Procedures | 1 | 2009 | 150 | 0.300 |
Why?
|
Practice Patterns, Physicians' | 3 | 2017 | 132 | 0.300 |
Why?
|
Disability Evaluation | 3 | 2019 | 327 | 0.300 |
Why?
|
Societies, Medical | 3 | 2018 | 190 | 0.300 |
Why?
|
Transplants | 2 | 2016 | 11 | 0.290 |
Why?
|
Arthrography | 4 | 2017 | 26 | 0.290 |
Why?
|
Image Processing, Computer-Assisted | 4 | 2015 | 220 | 0.280 |
Why?
|
Software | 3 | 2022 | 72 | 0.280 |
Why?
|
Stress, Mechanical | 6 | 2019 | 166 | 0.280 |
Why?
|
Equipment Design | 6 | 2020 | 184 | 0.280 |
Why?
|
Diagnostic Imaging | 4 | 2016 | 90 | 0.280 |
Why?
|
Body Height | 2 | 2015 | 33 | 0.270 |
Why?
|
Polyethylene | 3 | 2020 | 116 | 0.260 |
Why?
|
Tendon Transfer | 2 | 2015 | 23 | 0.260 |
Why?
|
Meta-Analysis as Topic | 2 | 2014 | 41 | 0.250 |
Why?
|
Fractures, Bone | 2 | 2016 | 73 | 0.250 |
Why?
|
Hospitalization | 4 | 2020 | 317 | 0.250 |
Why?
|
Odds Ratio | 3 | 2019 | 284 | 0.240 |
Why?
|
Musculoskeletal Pain | 3 | 2020 | 20 | 0.240 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 2 | 2018 | 107 | 0.240 |
Why?
|
Muscle Strength | 4 | 2017 | 127 | 0.240 |
Why?
|
Knee Joint | 5 | 2015 | 797 | 0.240 |
Why?
|
Epilepsy | 3 | 2018 | 104 | 0.230 |
Why?
|
Activities of Daily Living | 5 | 2020 | 501 | 0.230 |
Why?
|
Extracellular Vesicles | 1 | 2023 | 3 | 0.230 |
Why?
|
Exosomes | 1 | 2023 | 4 | 0.230 |
Why?
|
Machine Learning | 2 | 2022 | 54 | 0.230 |
Why?
|
Severity of Illness Index | 5 | 2016 | 1111 | 0.230 |
Why?
|
Axilla | 2 | 2021 | 11 | 0.230 |
Why?
|
Patient Safety | 2 | 2020 | 51 | 0.230 |
Why?
|
Tensile Strength | 3 | 2019 | 29 | 0.220 |
Why?
|
Blood Transfusion | 3 | 2019 | 64 | 0.220 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2014 | 339 | 0.220 |
Why?
|
Prognosis | 5 | 2013 | 840 | 0.220 |
Why?
|
Prosthesis Failure | 3 | 2019 | 556 | 0.220 |
Why?
|
Animals | 7 | 2023 | 4591 | 0.220 |
Why?
|
Workload | 2 | 2021 | 33 | 0.220 |
Why?
|
Posture | 2 | 2015 | 78 | 0.210 |
Why?
|
Operative Time | 3 | 2019 | 80 | 0.210 |
Why?
|
Torque | 4 | 2017 | 27 | 0.210 |
Why?
|
Equipment Failure | 4 | 2017 | 51 | 0.210 |
Why?
|
Biological Products | 1 | 2023 | 40 | 0.210 |
Why?
|
Disease Models, Animal | 3 | 2021 | 731 | 0.210 |
Why?
|
Fibrocartilage | 2 | 2015 | 9 | 0.210 |
Why?
|
Patient Discharge | 2 | 2020 | 149 | 0.210 |
Why?
|
Depressive Disorder | 1 | 2023 | 187 | 0.210 |
Why?
|
Health Care Costs | 2 | 2022 | 70 | 0.210 |
Why?
|
Random Allocation | 6 | 2019 | 146 | 0.210 |
Why?
|
Injections, Intra-Articular | 2 | 2019 | 88 | 0.210 |
Why?
|
Bone Density | 4 | 2013 | 134 | 0.200 |
Why?
|
Artificial Limbs | 1 | 2021 | 7 | 0.200 |
Why?
|
Skin | 2 | 2020 | 117 | 0.200 |
Why?
|
Bone Wires | 2 | 2012 | 13 | 0.200 |
Why?
|
Image Interpretation, Computer-Assisted | 2 | 2019 | 81 | 0.200 |
Why?
|
Patient-Specific Modeling | 1 | 2020 | 1 | 0.190 |
Why?
|
Health Care Sector | 1 | 2020 | 3 | 0.190 |
Why?
|
Personal Protective Equipment | 1 | 2020 | 10 | 0.190 |
Why?
|
Medicare | 2 | 2021 | 121 | 0.190 |
Why?
|
Materials Testing | 3 | 2017 | 137 | 0.190 |
Why?
|
Calibration | 1 | 2020 | 22 | 0.190 |
Why?
|
Bone Cements | 2 | 2020 | 99 | 0.190 |
Why?
|
Ulnar Neuropathies | 1 | 2020 | 3 | 0.190 |
Why?
|
Sheep Diseases | 1 | 2020 | 1 | 0.190 |
Why?
|
Sex | 1 | 2020 | 1 | 0.190 |
Why?
|
Clinical Decision-Making | 1 | 2020 | 36 | 0.190 |
Why?
|
Gender Identity | 1 | 2020 | 21 | 0.190 |
Why?
|
Osseointegration | 1 | 2020 | 76 | 0.180 |
Why?
|
Sprains and Strains | 1 | 2019 | 2 | 0.180 |
Why?
|
Frailty | 1 | 2020 | 38 | 0.180 |
Why?
|
Perioperative Care | 1 | 2020 | 52 | 0.180 |
Why?
|
Gram-Positive Bacterial Infections | 1 | 2020 | 57 | 0.180 |
Why?
|
Antibiotic Prophylaxis | 1 | 2020 | 36 | 0.180 |
Why?
|
Anesthesia, Conduction | 1 | 2020 | 30 | 0.180 |
Why?
|
Sports | 1 | 2020 | 36 | 0.180 |
Why?
|
Chronic Disease | 4 | 2012 | 495 | 0.180 |
Why?
|
Mental Recall | 1 | 2020 | 74 | 0.180 |
Why?
|
Supervised Machine Learning | 1 | 2019 | 10 | 0.180 |
Why?
|
Weight Lifting | 1 | 2019 | 9 | 0.180 |
Why?
|
Football | 2 | 2017 | 36 | 0.180 |
Why?
|
Matched-Pair Analysis | 1 | 2019 | 20 | 0.180 |
Why?
|
Autografts | 1 | 2019 | 32 | 0.170 |
Why?
|
Infant | 5 | 2018 | 531 | 0.170 |
Why?
|
Ulna | 1 | 2019 | 29 | 0.170 |
Why?
|
Political Activism | 1 | 2018 | 1 | 0.170 |
Why?
|
Attitude of Health Personnel | 1 | 2020 | 148 | 0.170 |
Why?
|
Betacoronavirus | 1 | 2020 | 75 | 0.170 |
Why?
|
Child, Preschool | 5 | 2018 | 642 | 0.170 |
Why?
|
Physical Exertion | 1 | 2018 | 9 | 0.170 |
Why?
|
Electroencephalography | 3 | 2018 | 140 | 0.170 |
Why?
|
Sex Characteristics | 1 | 2020 | 132 | 0.170 |
Why?
|
Osteolysis | 2 | 2017 | 149 | 0.170 |
Why?
|
Orthopedic Nursing | 1 | 1998 | 2 | 0.170 |
Why?
|
Multivariate Analysis | 2 | 2017 | 324 | 0.170 |
Why?
|
Diagnostic Self Evaluation | 1 | 2018 | 16 | 0.170 |
Why?
|
Health Policy | 1 | 2018 | 50 | 0.160 |
Why?
|
Tissue Transplantation | 2 | 2016 | 19 | 0.160 |
Why?
|
Depression | 2 | 2020 | 465 | 0.160 |
Why?
|
Adrenal Cortex Hormones | 1 | 2019 | 100 | 0.160 |
Why?
|
Pleura | 1 | 2017 | 9 | 0.160 |
Why?
|
Chromosome Disorders | 1 | 2018 | 20 | 0.160 |
Why?
|
Pleural Neoplasms | 1 | 2017 | 9 | 0.160 |
Why?
|
Mesothelioma | 1 | 2017 | 10 | 0.160 |
Why?
|
Patient Compliance | 2 | 2017 | 164 | 0.160 |
Why?
|
Female Athlete Triad Syndrome | 1 | 2017 | 3 | 0.160 |
Why?
|
Urinary Diversion | 1 | 2017 | 2 | 0.160 |
Why?
|
Leg Injuries | 1 | 2017 | 6 | 0.160 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2013 | 290 | 0.160 |
Why?
|
Brain Concussion | 1 | 2017 | 14 | 0.160 |
Why?
|
Radiotherapy, Intensity-Modulated | 1 | 2017 | 33 | 0.160 |
Why?
|
Models, Biological | 4 | 2013 | 343 | 0.150 |
Why?
|
Insurance Claim Review | 1 | 2017 | 6 | 0.150 |
Why?
|
Osteoporosis | 1 | 2018 | 80 | 0.150 |
Why?
|
Disease-Free Survival | 1 | 2017 | 175 | 0.150 |
Why?
|
Tarsal Bones | 1 | 2016 | 7 | 0.150 |
Why?
|
Decision Support Techniques | 2 | 2016 | 52 | 0.150 |
Why?
|
Patient Preference | 1 | 2017 | 33 | 0.150 |
Why?
|
Pressure | 2 | 2014 | 59 | 0.150 |
Why?
|
Electronic Health Records | 1 | 2017 | 66 | 0.150 |
Why?
|
Outpatients | 1 | 2017 | 52 | 0.150 |
Why?
|
Cell Proliferation | 2 | 2015 | 202 | 0.150 |
Why?
|
Lower Extremity | 1 | 2017 | 38 | 0.150 |
Why?
|
Hyaline Cartilage | 2 | 2013 | 15 | 0.150 |
Why?
|
Track and Field | 1 | 2016 | 1 | 0.150 |
Why?
|
Trauma Severity Indices | 1 | 1996 | 9 | 0.150 |
Why?
|
Fracture Fixation | 2 | 2015 | 24 | 0.150 |
Why?
|
Prostheses and Implants | 1 | 2017 | 166 | 0.140 |
Why?
|
Surgical Tape | 1 | 2015 | 3 | 0.140 |
Why?
|
Cartilage Diseases | 1 | 2017 | 83 | 0.140 |
Why?
|
Orthopedic Surgeons | 1 | 2016 | 27 | 0.140 |
Why?
|
Chondrogenesis | 1 | 2015 | 27 | 0.130 |
Why?
|
Propensity Score | 1 | 2015 | 34 | 0.130 |
Why?
|
Thoracic Nerves | 1 | 2015 | 3 | 0.130 |
Why?
|
Mononeuropathies | 1 | 2015 | 3 | 0.130 |
Why?
|
Video Recording | 1 | 2015 | 47 | 0.130 |
Why?
|
Sensitivity and Specificity | 4 | 2013 | 552 | 0.130 |
Why?
|
Paralysis | 1 | 2015 | 19 | 0.130 |
Why?
|
Extracellular Matrix Proteins | 1 | 2015 | 127 | 0.130 |
Why?
|
Thoracic Wall | 2 | 2012 | 8 | 0.130 |
Why?
|
Anterior Cruciate Ligament Injuries | 1 | 2017 | 259 | 0.130 |
Why?
|
Intercellular Signaling Peptides and Proteins | 2 | 2012 | 59 | 0.130 |
Why?
|
Clinical Trials as Topic | 2 | 2013 | 324 | 0.130 |
Why?
|
Ultrasonography | 3 | 2017 | 226 | 0.130 |
Why?
|
Functional Laterality | 2 | 2015 | 91 | 0.120 |
Why?
|
Arthritis, Rheumatoid | 1 | 2018 | 358 | 0.120 |
Why?
|
Reference Values | 3 | 2010 | 227 | 0.120 |
Why?
|
Boronic Acids | 1 | 2013 | 4 | 0.120 |
Why?
|
Pyrazines | 1 | 2013 | 10 | 0.120 |
Why?
|
Radiology | 1 | 2013 | 22 | 0.120 |
Why?
|
Models, Educational | 1 | 2013 | 36 | 0.120 |
Why?
|
Chondrocytes | 2 | 2012 | 197 | 0.120 |
Why?
|
Computer-Assisted Instruction | 1 | 2013 | 25 | 0.120 |
Why?
|
Immunocompromised Host | 1 | 2013 | 45 | 0.120 |
Why?
|
Multiple Myeloma | 1 | 2013 | 30 | 0.120 |
Why?
|
Injury Severity Score | 1 | 2013 | 15 | 0.120 |
Why?
|
Cytokines | 1 | 2015 | 347 | 0.120 |
Why?
|
Stem Cell Transplantation | 1 | 2013 | 40 | 0.120 |
Why?
|
Internet | 1 | 2014 | 91 | 0.120 |
Why?
|
Education, Medical, Continuing | 1 | 2013 | 45 | 0.120 |
Why?
|
Glycoproteins | 2 | 2005 | 58 | 0.120 |
Why?
|
Linear Models | 1 | 2013 | 254 | 0.110 |
Why?
|
Joint Dislocations | 1 | 2013 | 57 | 0.110 |
Why?
|
Cytomegalovirus Infections | 1 | 2013 | 79 | 0.110 |
Why?
|
Feasibility Studies | 1 | 2013 | 227 | 0.110 |
Why?
|
Guideline Adherence | 1 | 2013 | 67 | 0.110 |
Why?
|
Osteocytes | 1 | 2012 | 15 | 0.110 |
Why?
|
Models, Anatomic | 2 | 2013 | 52 | 0.110 |
Why?
|
Acute Disease | 1 | 2013 | 225 | 0.110 |
Why?
|
Evoked Potentials, Somatosensory | 1 | 2012 | 9 | 0.110 |
Why?
|
Muscle Fibers, Skeletal | 1 | 2012 | 38 | 0.110 |
Why?
|
Secondary Prevention | 1 | 2012 | 63 | 0.110 |
Why?
|
Osteochondritis | 1 | 2011 | 4 | 0.110 |
Why?
|
Lung Neoplasms | 1 | 2017 | 625 | 0.110 |
Why?
|
Antineoplastic Agents | 1 | 2013 | 218 | 0.100 |
Why?
|
Femur | 1 | 2015 | 396 | 0.100 |
Why?
|
Research Design | 1 | 2013 | 212 | 0.100 |
Why?
|
Bone Marrow | 2 | 2023 | 73 | 0.100 |
Why?
|
Cost-Benefit Analysis | 3 | 2016 | 144 | 0.100 |
Why?
|
Device Removal | 1 | 2011 | 85 | 0.100 |
Why?
|
Dermis | 2 | 2020 | 5 | 0.100 |
Why?
|
Work Capacity Evaluation | 1 | 2010 | 8 | 0.100 |
Why?
|
Practice Guidelines as Topic | 1 | 2013 | 333 | 0.090 |
Why?
|
Confidence Intervals | 1 | 2009 | 96 | 0.090 |
Why?
|
Adenoma, Pleomorphic | 1 | 2008 | 6 | 0.090 |
Why?
|
Radiographic Image Enhancement | 1 | 2008 | 16 | 0.090 |
Why?
|
Intraoperative Complications | 1 | 2009 | 68 | 0.090 |
Why?
|
Parotid Neoplasms | 1 | 2008 | 13 | 0.080 |
Why?
|
Musculoskeletal Diseases | 1 | 2009 | 41 | 0.080 |
Why?
|
Pilot Projects | 2 | 2019 | 393 | 0.080 |
Why?
|
Forecasting | 2 | 2019 | 117 | 0.080 |
Why?
|
Current Procedural Terminology | 2 | 2019 | 13 | 0.080 |
Why?
|
Character | 1 | 2007 | 1 | 0.080 |
Why?
|
Therapeutic Community | 1 | 2007 | 1 | 0.080 |
Why?
|
Temperament | 1 | 2007 | 11 | 0.080 |
Why?
|
Patient Dropouts | 1 | 2007 | 27 | 0.070 |
Why?
|
Regression Analysis | 3 | 2014 | 297 | 0.070 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2008 | 178 | 0.070 |
Why?
|
Braces | 1 | 2006 | 26 | 0.070 |
Why?
|
Ultrasonic Therapy | 1 | 2006 | 20 | 0.070 |
Why?
|
Bursa, Synovial | 1 | 2005 | 8 | 0.070 |
Why?
|
Hemostasis, Surgical | 1 | 2005 | 15 | 0.070 |
Why?
|
Electrocoagulation | 1 | 2005 | 16 | 0.070 |
Why?
|
Hemodiafiltration | 1 | 2005 | 1 | 0.070 |
Why?
|
Chronic Kidney Disease-Mineral and Bone Disorder | 1 | 2005 | 2 | 0.070 |
Why?
|
Burns | 1 | 2005 | 21 | 0.070 |
Why?
|
Receptors, Tumor Necrosis Factor | 1 | 2005 | 33 | 0.070 |
Why?
|
Internal Fixators | 1 | 2005 | 54 | 0.070 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2005 | 35 | 0.060 |
Why?
|
Collagen Type III | 2 | 2015 | 13 | 0.060 |
Why?
|
Collagen Type I | 2 | 2015 | 18 | 0.060 |
Why?
|
Bone and Bones | 1 | 2005 | 119 | 0.060 |
Why?
|
Surgical Instruments | 1 | 2004 | 25 | 0.060 |
Why?
|
Tenocytes | 1 | 2023 | 1 | 0.060 |
Why?
|
Medical Illustration | 2 | 2015 | 20 | 0.060 |
Why?
|
Drug Administration Schedule | 2 | 2019 | 223 | 0.060 |
Why?
|
Anterior Cruciate Ligament | 1 | 2005 | 270 | 0.060 |
Why?
|
Kidney Failure, Chronic | 1 | 2005 | 161 | 0.060 |
Why?
|
Head and Neck Neoplasms | 1 | 2004 | 133 | 0.060 |
Why?
|
Oxidative Stress | 2 | 2008 | 126 | 0.060 |
Why?
|
Decision Making | 1 | 2005 | 220 | 0.060 |
Why?
|
Disease Progression | 2 | 2018 | 788 | 0.050 |
Why?
|
Antibodies, Anticardiolipin | 1 | 2002 | 1 | 0.050 |
Why?
|
Prothrombin | 1 | 2002 | 4 | 0.050 |
Why?
|
Macrophages | 1 | 2023 | 129 | 0.050 |
Why?
|
Patient Acceptance of Health Care | 1 | 2023 | 79 | 0.050 |
Why?
|
Cells, Cultured | 2 | 2015 | 688 | 0.050 |
Why?
|
Rest | 1 | 2021 | 32 | 0.050 |
Why?
|
Nomograms | 1 | 2021 | 5 | 0.050 |
Why?
|
Arthroscopes | 1 | 2001 | 9 | 0.050 |
Why?
|
Status Epilepticus | 2 | 1995 | 48 | 0.050 |
Why?
|
Combined Modality Therapy | 2 | 2017 | 363 | 0.050 |
Why?
|
Delphi Technique | 1 | 2021 | 27 | 0.050 |
Why?
|
Rabbits | 2 | 2015 | 299 | 0.050 |
Why?
|
Cubital Tunnel Syndrome | 1 | 2020 | 3 | 0.050 |
Why?
|
Consensus | 1 | 2021 | 105 | 0.050 |
Why?
|
Bone-Implant Interface | 1 | 2019 | 6 | 0.050 |
Why?
|
Hematocrit | 1 | 2019 | 11 | 0.050 |
Why?
|
Episode of Care | 1 | 2019 | 5 | 0.040 |
Why?
|
Color | 1 | 1999 | 6 | 0.040 |
Why?
|
Serum Albumin | 1 | 2019 | 24 | 0.040 |
Why?
|
Skilled Nursing Facilities | 1 | 2019 | 20 | 0.040 |
Why?
|
Eyeglasses | 1 | 1999 | 3 | 0.040 |
Why?
|
Area Under Curve | 1 | 2019 | 66 | 0.040 |
Why?
|
Running | 1 | 1999 | 10 | 0.040 |
Why?
|
Basketball | 1 | 1999 | 10 | 0.040 |
Why?
|
ROC Curve | 1 | 2019 | 138 | 0.040 |
Why?
|
Insurance, Health | 1 | 2019 | 22 | 0.040 |
Why?
|
Receptors, Somatostatin | 1 | 1998 | 2 | 0.040 |
Why?
|
Gastrointestinal Neoplasms | 1 | 1998 | 14 | 0.040 |
Why?
|
Neuroendocrine Tumors | 1 | 1998 | 17 | 0.040 |
Why?
|
Light | 1 | 1999 | 76 | 0.040 |
Why?
|
Patella | 1 | 1999 | 81 | 0.040 |
Why?
|
Risk | 1 | 2019 | 217 | 0.040 |
Why?
|
Chromosomes, Human, Pair 15 | 1 | 2018 | 5 | 0.040 |
Why?
|
Smoking | 1 | 2019 | 192 | 0.040 |
Why?
|
Operating Rooms | 1 | 2018 | 14 | 0.040 |
Why?
|
Ketones | 1 | 2017 | 18 | 0.040 |
Why?
|
Benzophenones | 1 | 2017 | 27 | 0.040 |
Why?
|
Polymers | 1 | 2017 | 42 | 0.040 |
Why?
|
Michigan | 1 | 2017 | 16 | 0.040 |
Why?
|
Predictive Value of Tests | 1 | 2019 | 521 | 0.040 |
Why?
|
Reimbursement, Incentive | 1 | 2017 | 6 | 0.040 |
Why?
|
Polyethylene Glycols | 1 | 2017 | 55 | 0.040 |
Why?
|
Health Status Indicators | 2 | 2010 | 78 | 0.040 |
Why?
|
Analysis of Variance | 2 | 2010 | 321 | 0.040 |
Why?
|
Seizures | 1 | 2018 | 87 | 0.040 |
Why?
|
Pancreatic Neoplasms | 1 | 1998 | 142 | 0.040 |
Why?
|
Torso | 1 | 2017 | 7 | 0.040 |
Why?
|
Biopsy | 1 | 2017 | 234 | 0.040 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2017 | 30 | 0.040 |
Why?
|
G1 Phase | 1 | 1996 | 14 | 0.040 |
Why?
|
Saccharomyces cerevisiae | 1 | 1996 | 18 | 0.040 |
Why?
|
Knee | 1 | 2017 | 44 | 0.040 |
Why?
|
Evaluation Studies as Topic | 1 | 1996 | 56 | 0.040 |
Why?
|
Transcription, Genetic | 1 | 1996 | 109 | 0.040 |
Why?
|
Quality-Adjusted Life Years | 1 | 2016 | 23 | 0.040 |
Why?
|
Quality of Life | 1 | 2021 | 660 | 0.040 |
Why?
|
Knee Injuries | 1 | 1999 | 223 | 0.040 |
Why?
|
Oxygen | 1 | 1996 | 85 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-sis | 1 | 2015 | 3 | 0.030 |
Why?
|
Angelman Syndrome | 1 | 1995 | 2 | 0.030 |
Why?
|
Age Distribution | 1 | 2016 | 94 | 0.030 |
Why?
|
Probability | 2 | 2006 | 94 | 0.030 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2015 | 31 | 0.030 |
Why?
|
Photography | 1 | 2015 | 17 | 0.030 |
Why?
|
Epilepsies, Partial | 1 | 1995 | 24 | 0.030 |
Why?
|
Healthy Volunteers | 1 | 2015 | 46 | 0.030 |
Why?
|
Sports Medicine | 1 | 2016 | 41 | 0.030 |
Why?
|
Biocompatible Materials | 1 | 2016 | 114 | 0.030 |
Why?
|
Tissue Scaffolds | 1 | 2015 | 22 | 0.030 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2015 | 130 | 0.030 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2015 | 27 | 0.030 |
Why?
|
Models, Animal | 1 | 2015 | 126 | 0.030 |
Why?
|
X-Ray Microtomography | 1 | 2015 | 72 | 0.030 |
Why?
|
Thorax | 1 | 2014 | 12 | 0.030 |
Why?
|
Endoscopy | 1 | 1996 | 181 | 0.030 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2015 | 215 | 0.030 |
Why?
|
Bortezomib | 1 | 2013 | 5 | 0.030 |
Why?
|
Vincristine | 1 | 2013 | 26 | 0.030 |
Why?
|
Induction Chemotherapy | 1 | 2013 | 14 | 0.030 |
Why?
|
Markov Chains | 1 | 2013 | 29 | 0.030 |
Why?
|
Decision Trees | 1 | 2013 | 16 | 0.030 |
Why?
|
Learning Curve | 1 | 2013 | 18 | 0.030 |
Why?
|
Doxorubicin | 1 | 2013 | 45 | 0.030 |
Why?
|
Hip | 1 | 2013 | 40 | 0.030 |
Why?
|
Time-to-Treatment | 1 | 2013 | 32 | 0.030 |
Why?
|
Dexamethasone | 1 | 2013 | 48 | 0.030 |
Why?
|
Tenascin | 1 | 2013 | 2 | 0.030 |
Why?
|
Cost of Illness | 1 | 2013 | 54 | 0.030 |
Why?
|
Decorin | 1 | 2013 | 15 | 0.030 |
Why?
|
Equipment Failure Analysis | 1 | 2013 | 106 | 0.030 |
Why?
|
Blood Specimen Collection | 1 | 2012 | 11 | 0.030 |
Why?
|
Observer Variation | 1 | 2012 | 118 | 0.030 |
Why?
|
Erythrocytes | 1 | 2012 | 21 | 0.030 |
Why?
|
Leukocytes | 1 | 2012 | 43 | 0.030 |
Why?
|
Blood Platelets | 1 | 2012 | 50 | 0.030 |
Why?
|
Ankle Joint | 1 | 2011 | 39 | 0.030 |
Why?
|
Transducers | 1 | 2010 | 10 | 0.020 |
Why?
|
Medical History Taking | 1 | 2010 | 24 | 0.020 |
Why?
|
Occupations | 1 | 2010 | 15 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2010 | 138 | 0.020 |
Why?
|
In Vitro Techniques | 1 | 2010 | 214 | 0.020 |
Why?
|
Gymnastics | 1 | 2010 | 4 | 0.020 |
Why?
|
Anticonvulsants | 2 | 2002 | 109 | 0.020 |
Why?
|
Carcinoma, Mucoepidermoid | 1 | 2008 | 4 | 0.020 |
Why?
|
Adenolymphoma | 1 | 2008 | 4 | 0.020 |
Why?
|
Carcinoma, Acinar Cell | 1 | 2008 | 4 | 0.020 |
Why?
|
Calcitonin Gene-Related Peptide | 1 | 2008 | 15 | 0.020 |
Why?
|
Substance P | 1 | 2008 | 18 | 0.020 |
Why?
|
Axons | 1 | 2008 | 38 | 0.020 |
Why?
|
Contrast Media | 1 | 2008 | 125 | 0.020 |
Why?
|
Seizures, Febrile | 1 | 1987 | 2 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2008 | 392 | 0.020 |
Why?
|
Italy | 1 | 2007 | 14 | 0.020 |
Why?
|
Hip Joint | 1 | 2011 | 367 | 0.020 |
Why?
|
Personality Assessment | 1 | 2007 | 38 | 0.020 |
Why?
|
Personality Inventory | 1 | 2007 | 72 | 0.020 |
Why?
|
Compressive Strength | 1 | 2006 | 28 | 0.020 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 1 | 2007 | 42 | 0.020 |
Why?
|
Social Adjustment | 1 | 2007 | 28 | 0.020 |
Why?
|
Inflammation | 1 | 2008 | 344 | 0.020 |
Why?
|
Motivation | 1 | 2007 | 100 | 0.020 |
Why?
|
Brain | 1 | 1995 | 1689 | 0.020 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2007 | 343 | 0.020 |
Why?
|
Selection Bias | 1 | 2005 | 10 | 0.020 |
Why?
|
Fractures, Spontaneous | 1 | 2005 | 11 | 0.020 |
Why?
|
Equipment Safety | 1 | 2005 | 13 | 0.020 |
Why?
|
Bone Marrow Diseases | 1 | 2005 | 8 | 0.020 |
Why?
|
Osteonecrosis | 1 | 2005 | 19 | 0.020 |
Why?
|
Connective Tissue | 1 | 2005 | 25 | 0.020 |
Why?
|
Osteoprotegerin | 1 | 2005 | 7 | 0.020 |
Why?
|
Edema | 1 | 2005 | 38 | 0.020 |
Why?
|
Image Enhancement | 1 | 2005 | 57 | 0.020 |
Why?
|
Absorptiometry, Photon | 1 | 2005 | 76 | 0.020 |
Why?
|
Maximum Tolerated Dose | 1 | 2004 | 16 | 0.020 |
Why?
|
Radiation Dosage | 1 | 2004 | 31 | 0.020 |
Why?
|
Paclitaxel | 1 | 2004 | 74 | 0.020 |
Why?
|
Cisplatin | 1 | 2004 | 91 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2004 | 340 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2007 | 1442 | 0.010 |
Why?
|
beta 2-Glycoprotein I | 1 | 2002 | 7 | 0.010 |
Why?
|
Seroepidemiologic Studies | 1 | 2002 | 20 | 0.010 |
Why?
|
Biomarkers | 1 | 2005 | 691 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2002 | 604 | 0.010 |
Why?
|
Photic Stimulation | 1 | 1999 | 44 | 0.010 |
Why?
|
Elasticity | 1 | 1999 | 39 | 0.010 |
Why?
|
Videotape Recording | 1 | 1999 | 43 | 0.010 |
Why?
|
Whole-Body Counting | 1 | 1998 | 2 | 0.010 |
Why?
|
Somatostatin | 1 | 1998 | 5 | 0.010 |
Why?
|
Reaction Time | 1 | 1999 | 123 | 0.010 |
Why?
|
Radiopharmaceuticals | 1 | 1998 | 48 | 0.010 |
Why?
|
Action Potentials | 1 | 1999 | 144 | 0.010 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 1998 | 75 | 0.010 |
Why?
|
Liver Neoplasms | 1 | 1998 | 103 | 0.010 |
Why?
|
RNA, Fungal | 1 | 1996 | 1 | 0.010 |
Why?
|
Gene Expression Regulation, Fungal | 1 | 1996 | 1 | 0.010 |
Why?
|
Cyclins | 1 | 1996 | 6 | 0.010 |
Why?
|
Fungal Proteins | 1 | 1996 | 7 | 0.010 |
Why?
|
Movement Disorders | 1 | 1995 | 141 | 0.010 |
Why?
|
Nervous System Diseases | 1 | 1987 | 145 | 0.000 |
Why?
|